Bridge City Capital LLC Sells 8,458 Shares of Cognex Corporation $CGNX

by · The Markets Daily

Bridge City Capital LLC reduced its stake in shares of Cognex Corporation (NASDAQ:CGNX – Free Report) by 14.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 51,294 shares of the scientific and technical instruments company’s stock after selling 8,458 shares during the quarter. Bridge City Capital LLC’s holdings in Cognex were worth $1,846,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. CIBC Private Wealth Group LLC grew its stake in shares of Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after purchasing an additional 327 shares during the last quarter. Geneos Wealth Management Inc. grew its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 736 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Cognex by 207.6% in the third quarter. Smartleaf Asset Management LLC now owns 935 shares of the scientific and technical instruments company’s stock valued at $43,000 after acquiring an additional 631 shares during the last quarter. Rothschild Investment LLC boosted its stake in Cognex by 21,060.0% in the third quarter. Rothschild Investment LLC now owns 1,058 shares of the scientific and technical instruments company’s stock valued at $48,000 after acquiring an additional 1,053 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new position in Cognex in the fourth quarter valued at approximately $39,000. 88.12% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Mark Fennell sold 64,873 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the transaction, the insider owned 11,263 shares of the company’s stock, valued at $755,184.15. The trade was a 85.21% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Laura Ann Macdonald sold 98,122 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $66.80, for a total transaction of $6,554,549.60. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at $351,234.40. This trade represents a 94.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 224,847 shares of company stock valued at $14,975,098 in the last quarter. Company insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on CGNX. Truist Financial set a $61.00 price objective on shares of Cognex and gave the company a “hold” rating in a research note on Friday, May 8th. DA Davidson set a $62.00 price objective on shares of Cognex and gave the company a “neutral” rating in a research note on Thursday, May 14th. Seaport Research Partners set a $75.00 price objective on shares of Cognex in a research note on Tuesday, May 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cognex in a research note on Friday, May 15th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $80.00 price objective (up from $70.00) on shares of Cognex in a research note on Monday, May 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $70.43.

Read Our Latest Report on CGNX

Cognex Price Performance

Shares of CGNX stock opened at $63.61 on Friday. The stock has a market cap of $10.59 billion, a PE ratio of 75.73 and a beta of 1.52. The stock has a 50-day moving average of $59.69 and a 200-day moving average of $49.35. Cognex Corporation has a one year low of $29.22 and a one year high of $71.90.

Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $268.44 million during the quarter, compared to analyst estimates of $245.98 million. During the same quarter in the previous year, the business earned $0.14 EPS. The firm’s revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, research analysts anticipate that Cognex Corporation will post 1.41 earnings per share for the current year.

Cognex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were issued a $0.085 dividend. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s payout ratio is 40.48%.

Cognex Profile

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Featured Articles

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).